Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Mural Oncology plc (MURA) Insider Trading Activity
Healthcare • Biotechnology • 107 employees
Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
Total Value
-$135,028.02
Total Shares
139,237
Average Trade Value
-$11,252.34
Most Active Insider
Goodman Vicki L
Total Activity: $68,173
Largest Single Transaction
$51,294
by Goodman Vicki L on Feb 24, 2025
30-Day Activity
3 Transactions
Volume: 7,044 shares
Value: $23,800
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
See Remarks
|
Mar 5, 2025 | 1,469 | $5,068 | 73,564 (-2.0%) | Sale | |
|
Chief Executive Officer
|
Mar 4, 2025 | 4,313 | $14,492 | 305,590 (-1.4%) | Sale | |
|
See Remarks
|
Mar 4, 2025 | 1,262 | $4,240 | 75,033 (-1.7%) | Sale | |
|
Chief Executive Officer
|
Mar 3, 2025 | 72,275 | $0 | 309,903 (+23.3%) | Grant | |
|
Chief Financial Officer
|
Mar 3, 2025 | 35,000 | $0 | 106,438 (+32.9%) | Grant | |
|
Chief Medical Officer
|
Mar 3, 2025 | 35,000 | $0 | 89,763 (+39.0%) | Grant | |
|
See Remarks
|
Mar 3, 2025 | 35,000 | $0 | 76,295 (+45.9%) | Grant | |
|
Chief Medical Officer
|
Feb 24, 2025 | 13,186 | $51,294 | 54,763 (-24.1%) | Sale | |
|
See Remarks
|
Dec 23, 2024 | 2,555 | $8,355 | 41,295 (-6.2%) | Sale | |
|
Chief Executive Officer
|
Dec 17, 2024 | 2,763 | $9,394 | 237,628 (-1.2%) | Sale | |
|
Chief Medical Officer
|
Nov 7, 2024 | 5,069 | $16,880 | 67,949 (-7.5%) | Sale | |
|
Chief Financial Officer
|
Oct 31, 2024 | 7,421 | $25,306 | 71,438 (-10.4%) | Sale |